Joslin researchers discover protein that causes blood vessel leakage and swelling in eyes with diabetic retinopathy. Discovery one day could lead to new treatments for eye diseases and brain swelling caused by head injury, stroke and other conditions.
GAIKER-IK4 Technological Centre’s Area of Biotechnology, together with the Opthtalmological Surgery Clinical Institute of Bilbao (ICQO) are co-operating in a research project the aim of which is to develop a diagnostic system, based on immunochromatographic techniques, for the specific recognition of proteic markers for ocular pathologies in eye teardrop samples.
According to the National Eye Institute, Americans are facing increasing rates of visual impairment from age-related diseases. The articles in this special issue on vision address three general areas: screening for diabetic retinopathy, basic research on treating and preventing vision loss, and management of patients with low vision.
Using a new and dramatically effective treatment approach, scientists at the Scripps Research Institute have for the first time achieved complete inhibition of new blood vessel growth in animal models of a highly vascular brain tumor and of neovascular eye diseases with little or no effect on normal tissue vasculature.
Early sensory stimulation may not be required for vision development.
Surveys conducted in southern Sudan, after conflict there ended in 2004, found much higher levels of blindness than anticipated. The results, published in PLoS Medicine, have major implications for the provision of health services in the region.
A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, Johns Hopkins Wilmer Eye Institute scientists report.
A gene variant that increases the risk of developing the aggressive “wet” form of age-related macular degeneration, the most common cause of blindness in people over age 50, is reported in two recent articles in Science by researchers at Yale School of Medicine.
Pledging his eyes, Health Minister Anbumani Ramadoss today said that the country India hoped to achieve its target of vision to all by the year 2015.
A combined analysis of two landmark clinical glaucoma trials — the Ocular Hypertension Treatment Study (OHTS) and the European Glaucoma Prevention Study (EGPS) — confirms the benefit of a five-year risk assessment model to help ophthalmologists better predict which patients have an increased risk of developing glaucoma. Glaucoma is the second leading cause of blindness in the world, affecting approximately 70 million people, and can lead to blindness if left untreated. These new data were presented this week at the annual American Academy of Ophthalmology meeting.